Teleflex Inc (NYSE:TFX)
| 396.01 Delayed Data As of 3:59pm ET |  +0.31 / +0.08%Today’s Change | 312.33 Today|||52-Week Range 449.38 | -3.78% Year-to-Date |
Latest TFX News | Press Releases
| Teleflex (TFX) Procedure Volume Recovers as Pandemic Subsides Jun 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 395.70 |
| Today’s open | 394.67 |
| Day’s range | 393.96 - 399.13 |
| Volume | 269,686 |
| Average volume (3 months) | 202,562 |
| Market cap | $18.4B |
Data as of 3:59pm ET, 06/15/2021
Growth & Valuation
| Earnings growth (last year) | -27.79% |
| Earnings growth (this year) | +19.63% |
| Earnings growth (next 5 years) | +14.50% |
| Revenue growth (last year) | -2.24% |
| P/E ratio | 67.2 |
| Price/Sales | 7.67 |
| Price/Book | 5.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PODDInsulet Corp | -6.41 | -2.26% |
| WSTWest Pharmaceutical ... | -0.37 | -0.11% |
| ABMDABIOMED Inc | -0.96 | -0.32% |
| PENPenumbra Inc | -0.95 | -0.34% |
Data as of 4:00pm ET, 06/15/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $2.87 |
| Annual revenue (last year) | $2.5B |
| Annual profit (last year) | $335.3M |
| Net profit margin | 13.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Wayne, Pennsylvania |
Forecasts
